UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Reduced by Cherrydale Wealth Management LLC

Cherrydale Wealth Management LLC lowered its position in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 8.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 543 shares of the healthcare conglomerate’s stock after selling 52 shares during the quarter. Cherrydale Wealth Management LLC’s holdings in UnitedHealth Group were worth $256,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Chesapeake Wealth Management boosted its stake in UnitedHealth Group by 7.0% during the 4th quarter. Chesapeake Wealth Management now owns 4,992 shares of the healthcare conglomerate’s stock valued at $2,647,000 after purchasing an additional 326 shares during the period. Westhampton Capital LLC boosted its stake in UnitedHealth Group by 1.2% during the 1st quarter. Westhampton Capital LLC now owns 2,587 shares of the healthcare conglomerate’s stock valued at $1,223,000 after purchasing an additional 30 shares during the period. Two Sigma Investments LP bought a new stake in UnitedHealth Group during the 4th quarter valued at approximately $87,114,000. Beaumont Financial Advisors LLC bought a new stake in UnitedHealth Group during the 4th quarter valued at approximately $2,299,000. Finally, Ruedi Wealth Management Inc. acquired a new position in UnitedHealth Group in the 4th quarter valued at approximately $64,000. Institutional investors own 92.61% of the company’s stock.

Wall Street Analysts Forecast Growth

UNH has been the subject of several recent research reports. TD Cowen cut their price target on UnitedHealth Group from $596.00 to $562.00 and set an “outperform” rating for the company in a report on Monday, April 17th. Raymond James reaffirmed a “strong-buy” rating and issued a $630.00 price target on shares of UnitedHealth Group in a report on Friday, April 14th. Oppenheimer reissued an “outperform” rating and issued a $610.00 target price on shares of UnitedHealth Group in a report on Monday, April 17th. Deutsche Bank Aktiengesellschaft dropped their target price on UnitedHealth Group from $627.00 to $564.00 in a report on Friday, June 16th. Finally, Stephens reissued an “overweight” rating and issued a $605.00 target price on shares of UnitedHealth Group in a report on Tuesday, February 28th. One investment analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of “Buy” and an average price target of $592.68.

Insiders Place Their Bets

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,684 shares of UnitedHealth Group stock in a transaction dated Monday, April 24th. The stock was sold at an average price of $488.46, for a total transaction of $822,566.64. Following the transaction, the executive vice president now directly owns 8,675 shares in the company, valued at $4,237,390.50. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other news, CEO Andrew Witty sold 6,160 shares of the business’s stock in a transaction dated Thursday, April 27th. The stock was sold at an average price of $487.49, for a total value of $3,002,938.40. Following the sale, the chief executive officer now directly owns 86,564 shares in the company, valued at $42,199,084.36. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,684 shares of the business’s stock in a transaction dated Monday, April 24th. The shares were sold at an average price of $488.46, for a total value of $822,566.64. Following the completion of the sale, the executive vice president now owns 8,675 shares in the company, valued at $4,237,390.50. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 8,852 shares of company stock worth $4,313,962. Corporate insiders own 0.35% of the company’s stock.

UnitedHealth Group Stock Up 0.5 %

NYSE UNH opened at $479.20 on Tuesday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.81 and a current ratio of 0.81. UnitedHealth Group Incorporated has a 52 week low of $445.68 and a 52 week high of $558.10. The stock has a fifty day moving average of $484.66 and a 200-day moving average of $491.47. The stock has a market capitalization of $446.15 billion, a P/E ratio of 21.91, a price-to-earnings-growth ratio of 1.39 and a beta of 0.68.

UnitedHealth Group (NYSE:UNHGet Rating) last announced its quarterly earnings data on Friday, April 14th. The healthcare conglomerate reported $6.26 EPS for the quarter, topping analysts’ consensus estimates of $6.24 by $0.02. UnitedHealth Group had a return on equity of 27.05% and a net margin of 6.16%. The business had revenue of $91.93 billion during the quarter, compared to analysts’ expectations of $89.77 billion. During the same period in the previous year, the firm earned $5.49 earnings per share. The firm’s quarterly revenue was up 14.7% compared to the same quarter last year. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 24.86 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 27th. Shareholders of record on Monday, June 19th will be issued a dividend of $1.88 per share. The ex-dividend date is Thursday, June 15th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.65. This represents a $7.52 annualized dividend and a yield of 1.57%. UnitedHealth Group’s payout ratio is currently 34.39%.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.